General Information of the Compound
| Compound ID |
CP0495473
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-(3-Chloro-phenoxy)-[(S)-1-(2,6-dichloro-benzyl)-2-oxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl]-acetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H23Cl3N2O4
|
||||||||||||||||||
| Molecular Weight |
581.883
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)[C@@H](Oc1cccc(Cl)c1)[C@]1(NCC(=O)N(Cc2c(Cl)cccc2Cl)c2ccccc12)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H23Cl3N2O4/c31-20-10-6-11-21(16-20)39-28(29(37)38)30(19-8-2-1-3-9-19)23-12-4-5-15-26(23)35(27(36)17-34-30)18-22-24(32)13-7-14-25(22)33/h1-16,28,34H,17-18H2,(H,37,38)/t28-,30+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CSEUMOSCUZUMNY-DGPALRBDSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01783, Endothelin receptor type B
Protein ID: PT01372, Endothelin-1 receptor